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Optimal antimicrobial duration for  
common bacterial infections
SUMMARY
Most antibiotic use in Australia arises from prescriptions in the community.
The risk of antibiotic-related adverse events, including resistance, increases with longer 
treatment courses.
When antibiotics are indicated for treatment, short courses are as effective as standard ones for 
most common infections.
Therapeutic Guidelines: Antibiotic is a key reference for antimicrobial prescribing in Australia.
General practitioners play a key role in reducing antibiotic use.
Antibiotic.8 While other resources are commonly 
used, such as the Australian Medicines Handbook 
and MIMS, it is Therapeutic Guidelines that offers 
comprehensive information on the clinical indications 
for antibiotic prescription and advice on antibiotic 
choice, dose and duration. It is also the guideline 
currently endorsed by the Australian Commission 
on Safety and Quality in Health Care as the 
preferred reference for prescribing in the absence 
of local guidelines.
Antimicrobials are not always needed
Antibiotics are not necessary for most acute 
respiratory infections including acute rhinosinusitis, 
acute sore throat and acute otitis media. This is not 
just because so many of these infections are viral, 
but because even when the infection is bacterial, the 
benefits of antibiotic therapy for most patients are 
modest and outweighed by the harm from adverse 
effects.9-12 Australian and local guidelines provide 
recommendations on when antimicrobial therapy 
should be used for these conditions.8,13
Introduction
Optimising prescribing of antibiotics in the community 
is important because it is where most antibiotics are 
prescribed. In 2015, 30% of all patients attending a 
general practice received an antibiotic prescription.1 
Most are for acute respiratory infections, and in 
quantities several-fold more than recommended by 
Australian guidelines.2 Repeat prescriptions have been 
highlighted as a cause for over-use in this setting.1
Yet antibiotics are not entirely benign. Their use 
can be associated with adverse events such as 
toxicity, allergy (including anaphylaxis), candidiasis, 
Clostridium difficile infection, and antimicrobial 
resistance – both at community and individual 
levels.3-6 The more they are used, the greater the 
likelihood of adverse events, including resistance.4-7
It is important for prescribers to be up to date with 
best-practice antibiotic prescribing for common 
infections (Box), particularly the duration of 
treatment. In Australia, antibiotic prescribing is 
ideally concordant with the Therapeutic Guidelines: 
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Box    Best-practice antimicrobial prescribing in general practice
Do:
 • consider microbiological testing to direct therapy (e.g. urinary tract 
infection, abscess), especially when the causative organism is difficult 
to predict (e.g. recurrent or unresponsive infection, or overseas travel)
 • use the current version of Therapeutic Guidelines: Antibiotic, or 
available local guidelines
 • know why you are prescribing the antibiotic (document indication and 
duration in the medical record)
 • prescribe the shortest duration of therapy (or total number of tablets), 
even if this means the pharmacist breaking the pack.
Don’t:
 • culture every infection, or potential 
infection (especially urine in residential 
aged-care facilities)
 • prescribe an antimicrobial without an 
appropriate indication
 • routinely provide a repeat prescription.
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Practice points on optimising 
antibiotic prescribing
It can be difficult to clinically differentiate a patient 
with a trivial acute respiratory infection from one at an 
early stage of serious bacterial infection, particularly 
in children.14 One option is to ‘watch and wait’ and 
ask patients to return if there is clinical deterioration. 
An alternative is to prescribe an antibiotic but 
advise the patient to not have it dispensed unless 
specific symptoms occur. In the setting of acute 
respiratory infection, this has been shown to reduce 
antibiotic use by 50% with no significant decrease in 
patient satisfaction, and importantly no increase in 
complication rates.15
When antibiotics are prescribed, the duration 
(or number of tablets) should be written on the 
prescription. This should enable the pharmacist to 
supply only the number of tablets or capsules required 
(even if it means breaking the antibiotic pack) which 
avoids excessive antibiotic use. Repeat scripts are 
almost never required and we recommend changing 
the default setting to ‘no repeats’ in electronic 
prescribing software when technically feasible.
Antibiotic duration for 
common infections
Historically, the recommendations for duration of 
antibiotic treatment have been largely arbitrary. 
The theoretical principles have been to use enough 
antibiotic to eliminate the infecting organism and 
prevent the development of resistance. However, 
empirical evidence does not support this – shorter 
courses are nearly always as effective as standard 
ones.16 Also, the longer the antibiotic exposure, the 
greater the pressure to select for antibiotic resistance 
in commensal bacteria that may cause serious 
infection in the future.6,17
Currently recommended antibiotic durations for 
the most common bacterial infections managed in 
general practice are shown in the Table. The total 
tablet quantity for the suggested duration in adults 
is included.
Evidence for short-course 
antimicrobial therapy
There is evidence to support recommendations for 
shorter antibiotic courses.
Acute rhinosinusitis
A systematic review of 12 studies found no significant 
difference in clinical cure rate, microbiological efficacy 
and relapse when 3–7 days versus 6–10 days of 
antibiotics were given for acute bacterial sinusitis.16
Acute tonsillopharyngitis
Short-course antibiotic treatment (5–7 days vs 
standard 10 days) is associated with equivalent rates 
of clinical cure in acute tonsillopharyngitis.18 There 
is inferior bacteriological eradication, but this is of 
unknown clinical significance. It also is not known 
whether short-course therapy reduces the risk of 
non-suppurative complications (acute rheumatic 
fever and glomerulonephritis). A full 10-day course 
is still currently recommended to prevent these 
complications, especially in high-risk populations 
(previous history, remote indigenous populations).
Acute otitis media
A systematic review of short-course (<7 days) versus 
longer duration therapy in children with acute otitis 
media found that short-course therapy is non-
inferior for clinical cure measured at one month 
and is associated with a significant reduction in 
gastrointestinal adverse events.19
Mild community-acquired pneumonia
Australian studies show that a penicillin and 
doxycycline (or a macrolide) is effective and safe for 
most patients with community-acquired pneumonia.20 
Monotherapy is recommended for mild infections 
providing the patient’s progress can be reviewed 
after 48 hours.8 A duration of 5–7 days of antibiotics 
is recommended in adults. This is supported by a 
systematic review showing no significant difference 
in outcomes between 3–7 days of antibiotics 
compared to 7 days or longer.16 For children with 
non-severe pneumonia there is no difference 
between 3 versus 5 days of antibiotics.21 Therapeutic 
Guidelines: Antibiotic currently recommends 5 days 
of oral antibiotics.8 However, 3 days is endorsed 
by other Australian expert groups such as the 
Australian and New Zealand Paediatric Infectious 
Diseases group.22
Acute uncomplicated urinary tract infection
The evidence for antibiotic duration in urinary tract 
infections is sparser than for acute respiratory 
infections. For uncomplicated urinary tract infections 
in women there is no significant difference in clinical 
cure rates, and fewer adverse events in those given 
3 days of antibiotics versus 5 days or longer.23 
However, the risk of bacteriological failure is higher in 
women given a shorter course. Bacterial elimination 
from the urine is likely to be relevant for women who 
are pregnant, experience recurrent and painful urinary 
tract infections or who have urinary tract prosthetic 
material in situ (e.g. stent or catheter).
Antimicrobial duration for common bacterial infections
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Table    Recommended antibiotic prescribing for common bacterial infections *
Diagnosis Indications for 
antibiotic therapy
First-line antimicrobial (if indicated) Duration Tablets (for maximum 
adult dose)
Acute 
tonsillopharyngitis
2–25 years, high risk of 
acute rheumatic fever, 
or rheumatic heart 
disease, or scarlet fever
Phenoxymethylpenicillin 12-hourly 10 days † 20 x 500 mg
Acute rhinosinusitis Symptoms >7 days, or 
high fever >3 days, or 
biphasic illness
Amoxicillin 8-hourly 5 days † 15 x 500 mg
Acute otitis media <6 months old, or 
systemic symptoms, or 
indigenous community
Non-indigenous: amoxicillin 12-hourly
Indigenous: amoxicillin 12-hourly
5 days †
7 days †
20 x 500 mg
28 x 500 mg
Community-acquired 
pneumonia (mild, can 
review progress in 
48 hours)
Adults: amoxicillin 8-hourly, or doxycycline 
12-hourly
Children:
 • 1 month to <3 months: azithromycin daily ‡
 • 3 months to <5 years: amoxicillin 8-hourly
 • 5 years or older: amoxicillin 8-hourly §
5–7 days#
 
3–5 days
3–5 days †
3–5 days †
30 x 500 mg / 10 x 100 mg
 
–
–
–
Uncomplicated urinary 
tract infection
Non-pregnant women: trimethoprim daily
Pregnant women: cefalexin or nitrofurantoin 
12-hourly
Men: trimethoprim daily
Children ≥1 month: trimethoprim/
sulfamethoxazole 12-hourly
3 days
5 days
 
7 days
3–5 days ¶
3 x 300 mg
10 x 500 mg / 10 x 100 mg
 
7 x 300 mg
–
Cellulitis (mild, low risk 
for methicillin-resistant 
Staphylococcus aureus)
Dicloxacillin or flucloxacillin 6-hourly, or
phenoxymethylpenicillin 6-hourly **
5 days ††
5 days † , ††
20 x 500 mg
20 x 500 mg
Impetigo Non-remote setting:
 • Localised lesion: topical mupirocin
 • Multiple lesions/recurrent: dicloxacillin or 
flucloxacillin 6-hourly
Remote setting:
 • trimethoprim/sulfamethoxazole 12-hourly, or
 • benzathine penicillin intramuscular
7 days
3–10 days ‡‡
 
5 days
single dose
–
40 x 500 mg
 
10 x 160/800 mg
–
Abscess (low risk for 
methicillin-resistant 
Staphylococcus aureus)
Spreading cellulitis, or 
systemic symptoms, or 
large lesion/critical area
Dicloxacillin or flucloxacillin 6-hourly, as an 
adjunct to incision and drainage
5 days 20 x 500 mg
*  As recommended by Therapeutic Guidelines: Antibiotic. Refer to the complete guideline for further information on indications for antibiotic dosing, 
second-line antibiotics, and when broader spectrum therapy and specialist involvement may be appropriate. Refer also to local guidelines. Use oral 
regimen unless indicated otherwise.
†  Repeat script required only if using liquid formulation for a large child.
‡  Chlamydia trachomatis may be the cause in this age group if afebrile and only mildly unwell.
§  Atypical cover with doxycycline, azithromycin or clarithromycin is recommended if Mycoplasma pneumoniae or another atypical pathogen is 
suspected. Doxycycline should not be used in children younger than 8 years of age.
#  Repeat prescription required only if using amoxicillin.
¶  5 days for children <1 year, 3 days for children ≥1 year.
**  If Streptococcus pyogenes clinically suspected or isolated from culture.
††  Up to 10 days if cellulitis more severe.
‡‡  Stop therapy earlier than 10 days if infection has resolved.
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Currently 5 days of therapy is recommended 
for pregnant women and for second-line drugs 
in non-pregnant women.8 The first-line 3-day 
recommendation of trimethoprim in non-pregnant 
women has been extrapolated from data for 
trimethoprim/sulfamethoxazole, a drug that 
is considered equivalent to trimethoprim for 
this condition.24
Short-course therapy has not been adequately 
evaluated in men and so it is not recommended at 
present. A Cochrane review of childhood lower urinary 
tract infection found no difference in persistent 
bacteriuria or recurrence when comparing 2–4 days 
with 7–14 days of oral antibiotics.25
Oral fosfomycin has recently been registered for 
use in Australia as a single-dose treatment for 
uncomplicated urinary tract infections in females over 
the age of 12 years. However, this antibiotic should 
generally be reserved for resistant organisms.
Skin and soft tissue infections
There is a lack of systematic review data to guide 
short-course therapy for skin and soft tissue infection.
Incision and drainage is the primary therapeutic 
modality for soft tissue abscesses. A recently 
published systematic review found that for 
uncomplicated abscesses, adjunctive antibiotic 
therapy provides a modest benefit in terms of 
treatment success and prevention of recurrence,26 
but this needs to be balanced against an increased 
risk of adverse events. Antibiotic courses ranged 
from 3–14 days and no recommendation on duration 
was made.26
A randomised controlled trial conducted in the 
remote Australian setting showed that short-course 
oral trimethoprim/sulfamethoxazole for 3–5 days is 
effective for impetigo, and equivalent to intramuscular 
benzathine penicillin.27
Stopping antibiotics earlier than the 
intended standard duration
Since many common infections are spontaneously 
remitting, the use of antibiotics is often discretionary. 
Numerous opinions have been published in support of 
stopping antibiotics earlier.28-30
A practical approach in the community setting is 
to educate patients and advise them that it is safe 
to cease the antibiotics early if microbiological 
results exclude a bacterial cause for their 
symptoms (e.g. negative urine culture or viral acute 
respiratory infection), or the patient feels better 
for conditions where the benefit of antibiotics is 
small and the infection is not severe (e.g. acute 
respiratory infections).
Patients should be advised to return any remaining 
antibiotics to the pharmacy for safe disposal, rather 
than storing them (which risks future inappropriate 
use) or disposing of them in general household waste 
(which risks environmental contamination).
Conclusion
There is good evidence that shorter durations of 
antimicrobials can reduce adverse effects associated 
with their use. Furthermore, systematic reviews have 
found that clinical outcomes are similar between short 
and long courses for many common infections. Given 
Australia’s relatively high rates of prescribing, we 
can all play a significant role in reducing the burden 
of inappropriate antimicrobial use by prescribing 
short-course therapy when appropriate and limiting 
prescriptions when they are not indicated. 
Christopher Del Mar has been awarded grants by the 
National Health and Medical Research Council for 
research into antibiotic resistance in primary care, and 
for the Cochrane Acute Respiratory Infections Group.
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